CClinicalTrials.gg
CompletedNCT01999244Updated Sep 23, 2015

Impact of Self-Monitoring Technology and Interventionist Contact on Weight Loss

An interventional study of Self-monitoring skills and Technology in Overweight and Obesity, sponsored by The Miriam Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2015-09-23.

Sponsored by The Miriam Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Despite continued research on effective interventions, obesity remains a major public health issue in the United States. Current treatments, including behavioral weight management programs, weight loss surgery, and pharmacotherapy, tend to be high in cost and have limited reach, reducing the ability of these treatments to address the population-wide scope of the obesity epidemic. Recent advances in technology that improve the ease of self-monitoring and provide targeted feedback offer promise to help larger groups of individuals to lose weight. Despite the commercial popularity of these products, however, little research has been conducted to evaluate their impact on excess body weight or to determine how they should ideally be implemented. Two key questions need to be addressed. First, is use of self-monitoring technology sufficient to produce weight loss, or must this technology be combined with interventionist contact? Second, how cost-effective is a technology-based intervention, with and without interventionist contact? The current study is small prospective, randomized pilot study comparing a self-guided self-monitoring condition (SC) to a technology only condition (TECH) and a technology plus interventionist support condition (TECH+INT). All participants will all be given basic weight management information knowledge and randomized to one of three conditions. Participants in the self-guided self-monitoring condition (SC) will receive traditional paper self-monitoring logs, a standard body weight scale, and a pedometer and calorie book; participants in the technology-based condition (TECH) will receive an electronic activity monitor and WiFi-enabled body weight scale, and will track caloric intake via an associated website; and participants in the interventionist contact condition (TECH+INT) will receive the same technology as in the TECH condition, combined with weekly interventionist contact delivered via telephone. We will compare the impact of each condition on weight loss and investigate preliminary cost-effectiveness.

02

Conditions studied

  • Overweight
  • Obesity

Keywords

  • Overweight
  • Obesity
  • Weight Loss
  • Self-monitoring
  • Food Records
  • Self-weighing
  • Technology
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 80 is close to the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

The Miriam Hospital is the lead sponsor of 178 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 18 and 70
  • BMI between 27 and 40 kg/m2
  • Access to a computer and WIFI in the home

Exclusion criteria

Exclusion Criteria:

  • Weight over 340 lbs
  • Physical limitations that prevent walking 1/4 mile without stopping
  • Currently participating in another weight loss program or taking weight loss medication
  • Currently pregnant, lactating, less than 6-months post-partum, or plans to become pregnant during the 6-month study period
  • Uncontrolled hypertension or diabetes
  • History of coronary heart disease
  • Terminal Illness
  • Plans to relocate during the 6-month study period
  • Substance Abuse
  • Severe psychiatric disorders
  • Dementia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    SC

    Self-guided self-monitoring condition. Participants will receive standard self-monitoring tools and information on weight regulation.

    Behavioral: Self-monitoring skills

  • Experimental
    TECH

    Technology condition. Participants will receive self-monitoring technology and information regarding weight regulation.

    Behavioral: Self-monitoring skills · Behavioral: Technology

  • Experimental
    TECH+INT

    Technology plus interventionist contact arm. Participants will receive self-monitoring technology, information regarding weight regulation, and interventionist contact via telephone.

    Behavioral: Self-monitoring skills · Behavioral: Technology · Behavioral: Interventionist Contact

Interventions

  • BehavioralSelf-monitoring skills
  • BehavioralTechnology
  • BehavioralInterventionist Contact
06

What researchers measure

Primary outcomes

  1. Weight

    Time frame: 6 months post randomization

07

Study locations

1 site
  • Weight Control & Diabetes Research Center
    Providence, Rhode Island 02903, United States
08

References and documents

Publications

  • Chhabria K, Ross KM, Sacco SJ, Leahey TM. The Assessment of Supportive Accountability in Adults Seeking Obesity Treatment: Psychometric Validation Study. J Med Internet Res. 2020 Jul 28;22(7):e17967. doi: 10.2196/17967. PubMed 32720911 ↗
  • Ross KM, Wing RR. Impact of newer self-monitoring technology and brief phone-based intervention on weight loss: A randomized pilot study. Obesity (Silver Spring). 2016 Aug;24(8):1653-9. doi: 10.1002/oby.21536. Epub 2016 Jul 1. PubMed 27367614 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01999244
Lead sponsor
The Miriam Hospital
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Sponsor
First posted
Dec 3, 2013
Start date
Dec 2013
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Sep 23, 2015

Study contacts

Kathryn M Ross, PhD MPH
principal investigator · The Miriam Hospital
Rena R Wing, PhD
principal investigator · The Miriam Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion